Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II randomized double-blind placebo-controlled study of MWN109 tablets in non-diabetic adults with overweight or obesity
CTR20254820Phase 2Active
- Sponsor
- Shanghai Minwei Biotechnology Co., Ltd.
- Start
- Jan 2026
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of MWN109 in obesity, Overweight, sponsored by Shanghai Minwei Biotechnology Co., Ltd.. Started Jan 2026; status: active.
02
Drugs
MWN109
03
Conditions
obesityOverweight
Beyond the preview
Go deeper on CTR20254820.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20254820.